EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children

Sarah R Haile, Alessia Raineri, Sonja Rueegg, Thomas Radtke, Agne Ulyte, Milo A Puhan, Susi Kriemler

Swiss Medical Weekly · 2023

DOI: 10.57187/smw.2023.40035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Swiss Medical Weekly, 2023. Verfasst von Sarah R Haile und 6 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Much remains unknown regarding the evolution of SARS-CoV-2 seroprevalence and variability in seropositive children in districts, schools and classes as only a few school-based cohort studies exist. Vaccination of children, initiated at different times for different age groups, adds additional complexity to the understanding of how seroprevalence developed in the school aged population. AIM: We investigated the evolution of SARS-CoV-2 seroprevalence in children and its variability in districts, schools and classes in Switzerland from June/July 2020 to November/December 2021. METHODS: In this school-based cohort study, SARS-CoV-2 antibodies were measured in primary and secondary school children from randomly selected schools in the canton of Zurich in October/November 2020, March/April 2021 and November/December 2021. Seroprevalence was estimated using Bayesian logistic regression to adjust for test sensitivity and specificity. Variability of seroprevalence between school classes was expressed as maximum minus minimum seroprevalence in a class and summarised as median (interquartile range). RESULTS: 1875 children from 287 classes in 43 schools were tested, with median age 12 years (range 6–17), 51% 12+ vaccinated. Seroprevalence increased from 5.6% (95% credible interval [CrI] 3.5–7.6%) to 31.1% (95% CrI 27.0–36.1%) in unvaccinated children, and 46.4% (95% CrI 42.6–50.9%) in all children (including vaccinated). Earlier in the pandemic, seropositivity rates in primary schools were similar to or slightly higher (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansChildAdolescentBayes TheoremCohort StudiesSARS-CoV-2Seroepidemiologic StudiesAntibodies, ViralSchools

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Zitieren

APA

Haile, S. R., Raineri, A., Rueegg, S., Radtke, T., Ulyte, A., Puhan, M. A., & Kriemler, S. (2023). Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children. Swiss Medical Weekly. https://doi.org/10.57187/smw.2023.40035

Vancouver

Haile SR, Raineri A, Rueegg S, Radtke T, Ulyte A, Puhan MA, et al. Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children. Swiss Medical Weekly. 2023. doi:10.57187/smw.2023.40035

BibTeX
@article{Haile2023,
  author = {Haile, Sarah R and Raineri, Alessia and Rueegg, Sonja and Radtke, Thomas and Ulyte, Agne and Puhan, Milo A and Kriemler, Susi},
  title = {Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children},
  journal = {Swiss Medical Weekly},
  year = {2023},
  doi = {10.57187/smw.2023.40035}
}
Kostenlos starten →